HomeWINT • NASDAQ
Windtree Therapeutics Inc
$2.66
Sep 27, 1:22:47 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$2.71
Day range
$2.64 - $2.80
Year range
$2.60 - $27.00
Market cap
4.28M USD
Avg Volume
1.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
——
Operating expense
11.45M173.77%
Net income
-12.02M-82.15%
Net profit margin
——
Earnings per share
-20.91-16.25%
EBITDA
-11.37M-173.27%
Effective tax rate
-1.67%—
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
1.80M-84.28%
Total assets
28.71M-29.25%
Total liabilities
25.21M-12.97%
Total equity
3.49M—
Shares outstanding
591.91K—
Price to book
0.46—
Return on assets
-97.36%—
Return on capital
-243.97%—
Net change in cash
(USD)Jun 2024Y/Y change
Net income
-12.02M-82.15%
Cash from operations
-2.33M33.49%
Cash from investing
-12.00K—
Cash from financing
1.59M-85.13%
Net change in cash
-744.00K-110.31%
Free cash flow
-4.24M-66.34%
About
Windtree Therapeutics, Inc. is an American company which was set up in 1992 and now is based in Warrington, Pennsylvania, developing drug products for patients with respiratory disease. The company joined an alliance with Laboratorios del Dr. Esteve, S.A. In 2016, Discovery Laboratories changed name to Windtree Therapeutics, Inc. Wikipedia
Founded
Nov 6, 1992
Employees
15
Search
Clear search
Close search
Google apps
Main menu